#ExpertAnswers: Brian Brockway and Robert Hamlin on Wireless Monitoring Technology
Airdate: Thursday, May 29, 2014 Season: 1 Episode: 5
Guests: Brian Brockway, Robert Hamlin
This episode of #ExpertAnswers features Brian Brockway, President and CEO of VivaQuant, and Robert Hamlin, Professor at Ohio State University and Scientific Director of QTest Labs. They are here to discuss the history of wireless monitoring technology as applied in preclinical physiology, drug discovery, safety pharmacology and toxicology applications.
For more information or to watch the webinar, click here.
Associated Webinar: The Evolution of Wireless Monitoring and Review of Industry Standards in Drug-discovery and Safety Pharmacology and Toxicology
Similar Podcasts
#ExpertAnswers: Artur Federowoski on Cardiovascular Dysautonomia in Post-COVID-19
Artur Federowski explains CV dysautonomia as a specific sequalae of acute COVID-19 and guides the audience in the diagnostic work-up of PASC patients with suspected cardiovascular complications.
#ExpertAnswers: Phil Griffiths on Telemetry Studies
Phil Griffiths draws from his experience as a telemetry user to discuss some important considerations for designing telemetry studies.
#ExpertAnswers: Cole McLarty, Nick Glover, and Tim Hacker on Pressure-Volume Loops
Cole McLarty, Nick Glover and Dr. Timothy Hacker focus on Pressure-Volume Loop collection and data analysis for cardiovascular research.
Related Content
Cardiovascular Autonomic Dysfunction in the Post-COVID Landscape: Detection and Management
Artur Fedorowski, MD, PhD, describes cardiovascular dysautonomia in COVID-19 and the diagnostics behind detecting Long COVID or Post-acute Sequalae of COVID-19.
APS Physiology in Disease Modeling and Drug Development Roundtable
Key opinion leaders in cardiovascular physiology and bioengineering discuss best practices and challenges when modeling cardiomyopathies and other cardiovascular diseases using stem cells, engineered tissues and other novel platforms.
Experimental Design Considerations to Optimize Chronic Cardiovascular Telemetry Studies
Phil Griffiths, PhD, presents a summary of chronic cardiovascular telemetry studies and considerations for experimental design.